How Major Chains Are Already Responding The national chains that have moved first on GLP-1 adaptation share a common strategic logic: protein-forward positioning, portion optionality, and explicit callouts of nutrient density
One in 250 people have FH, and only about 20% of people with FH have been identified or recognized
However, the actual number of users might be even higher, as many people access the drug without appropriate medical supervision, often due to insurance limitations
These effects are temporary and can be managed with proper fluid intake, nutrition, and gentle movement
GPL-1R KO mice had a significantly lower SUV in the whole brain compared to WT mice (Unpaired t -test, p = 0.025, Fig